Eiger BioPharmaceuticals Files for Voluntary Chapter 11 Protection
April 01, 2024 11:12 ET
|
Eiger BioPharmaceuticals, Inc.
Announces “Stalking Horse” Agreement for the Sale of Zokinvy® (lonafarnib) Patient Access to Zokinvy® to Continue Uninterrupted PALO ALTO, Calif., April 01, 2024 (GLOBE NEWSWIRE) -- Eiger...
Eiger BioPharmaceuticals to Present at the 5th Annual Liolios Gateway Conference on September 7, 2016
September 01, 2016 08:00 ET
|
Eiger BioPharmaceuticals, Inc.
PALO ALTO, Calif., Sept. 01, 2016 (GLOBE NEWSWIRE) -- Eiger BioPharmaceuticals, Inc. (Nasdaq:EIGR) has been invited to present at the 2016 Gateway Conference being held on September 7-8, 2016 at...